全文获取类型
收费全文 | 1556223篇 |
免费 | 123002篇 |
国内免费 | 22862篇 |
专业分类
耳鼻咽喉 | 18685篇 |
儿科学 | 45537篇 |
妇产科学 | 39092篇 |
基础医学 | 223074篇 |
口腔科学 | 39728篇 |
临床医学 | 159238篇 |
内科学 | 286353篇 |
皮肤病学 | 28333篇 |
神经病学 | 124248篇 |
特种医学 | 56989篇 |
外国民族医学 | 564篇 |
外科学 | 205487篇 |
综合类 | 71023篇 |
一般理论 | 483篇 |
预防医学 | 127191篇 |
眼科学 | 36595篇 |
药学 | 124725篇 |
211篇 | |
中国医学 | 18405篇 |
肿瘤学 | 96126篇 |
出版年
2021年 | 19007篇 |
2020年 | 16347篇 |
2019年 | 18958篇 |
2018年 | 23115篇 |
2017年 | 20111篇 |
2016年 | 19501篇 |
2015年 | 25919篇 |
2014年 | 34886篇 |
2013年 | 43601篇 |
2012年 | 61419篇 |
2011年 | 66617篇 |
2010年 | 39501篇 |
2009年 | 34481篇 |
2008年 | 55318篇 |
2007年 | 57618篇 |
2006年 | 58056篇 |
2005年 | 56813篇 |
2004年 | 49270篇 |
2003年 | 46636篇 |
2002年 | 44264篇 |
2001年 | 65677篇 |
2000年 | 68065篇 |
1999年 | 58481篇 |
1998年 | 18097篇 |
1997年 | 16741篇 |
1996年 | 15667篇 |
1995年 | 15798篇 |
1994年 | 14387篇 |
1993年 | 12723篇 |
1992年 | 43443篇 |
1991年 | 42358篇 |
1990年 | 40795篇 |
1989年 | 38468篇 |
1988年 | 35518篇 |
1987年 | 34453篇 |
1986年 | 32702篇 |
1985年 | 31099篇 |
1984年 | 23254篇 |
1983年 | 19686篇 |
1982年 | 11766篇 |
1979年 | 20833篇 |
1978年 | 14769篇 |
1977年 | 12003篇 |
1976年 | 11814篇 |
1975年 | 12063篇 |
1974年 | 14743篇 |
1973年 | 14433篇 |
1972年 | 13329篇 |
1971年 | 12388篇 |
1970年 | 11460篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Tyler B. Kratzer MPH Ahmedin Jemal DVM PhD Kimberly D. Miller MPH Sarah Nash PhD Charles Wiggins PhD Diana Redwood PhD Robert Smith PhD Rebecca L. Siegel MPH 《CA: a cancer journal for clinicians》2023,73(2):120-146
American Indian and Alaska Native (AIAN) individuals are diverse culturally and geographically but share a high prevalence of chronic illness, largely because of obstacles to high-quality health care. The authors comprehensively examined cancer incidence and mortality among non-Hispanic AIAN individuals, compared with non-Hispanic White individuals for context, using population-based data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries. Overall cancer rates among AIAN individuals were 2% higher than among White individuals for incidence (2014 through 2018, confined to Purchased/Referred Care Delivery Area counties to reduce racial misclassification) but 18% higher for mortality (2015 through 2019). However, disparities varied widely by cancer type and geographic region. For example, breast and prostate cancer mortality rates are 8% and 31% higher, respectively, in AIAN individuals than in White individuals despite lower incidence and the availability of early detection tests for these cancers. The burden among AIAN individuals is highest for infection-related cancers (liver, stomach, and cervix), for kidney cancer, and for colorectal cancer among indigenous Alaskans (91.3 vs. 35.5 cases per 100,000 for White Alaskans), who have the highest rates in the world. Steep increases for early onset colorectal cancer, from 18.8 cases per 100,000 Native Alaskans aged 20–49 years during 1998 through 2002 to 34.8 cases per 100,000 during 2014 through 2018, exacerbated this disparity. Death rates for infection-related cancers (liver, stomach, and cervix), as well as kidney cancer, were approximately two-fold higher among AIAN individuals compared with White individuals. These findings highlight the need for more effective strategies to reduce the prevalence of chronic oncogenic infections and improve access to high-quality cancer screening and treatment for AIAN individuals. Mitigating the disparate burden will require expanded financial support of tribal health care as well as increased collaboration and engagement with this marginalized population. 相似文献
2.
Carlos Casas-Arozamena Cristian Pablo Moiola Ana Vilar Marta Bouso Juan Cueva Silvia Cabrera Victoria Sampayo Efigenia Arias Alicia Abalo Ángel García Ramón Manuel Lago-Lestón Sara Oltra Eva Díaz Juan Ruiz-Bañobre Rafael López-López Gema Moreno-Bueno Antonio Gil-Moreno Eva Colás Miguel Abal Laura Muinelo-Romay 《International journal of cancer. Journal international du cancer》2023,152(10):2206-2217
The analysis of mismatch repair proteins in solid tissue is the standard of care (SoC) for the microsatellite instability (MSI) characterization in endometrial cancer (EC). Uterine aspirates (UAs) or circulating-DNA (cfDNA) samples capture the intratumor heterogeneity and provide a more comprehensive and dynamic molecular diagnosis. Thus, MSI analysis by droplet-digital PCR (ddPCR) in UAs and cfDNA can provide a reliable tool to characterize and follow-up the disease. The UAs, paraffin-embedded tumor tissue (FFPE) and longitudinal plasma samples from a cohort of 90 EC patients were analyzed using ddPCR panel and compared to the SoC. A high concordance (96.67%) was obtained between the analysis of MSI markers in UAs and the SoC. Three discordant cases were validated as unstable by ddPCR on FFPE samples. Besides, a good overall concordance (70.27%) was obtained when comparing the performance of the ddPCR assay on UAs and cfDNA in high-risk tumors. Importantly, our results also evidenced the value of MSI analysis to monitor the disease evolution. MSI evaluation in minimally invasive samples shows great accuracy and sensitivity and provides a valuable tool for the molecular characterization and follow-up of endometrial tumors, opening new opportunities for personalized management of EC. 相似文献
3.
4.
Spindler L. Alam A. Fathallah N. Rentien A.-L. Draullette M. Pommaret E. Thierry M.-L. Mituialy A. El Abbes L. Aubert M. Benfredj P. Far E. Safa Beaussier H. de Parades V. 《Techniques in coloproctology》2022,26(2):143-146
Techniques in Coloproctology - The aim of our study was to assess the efficacy of sinus laser therapy (SiLaT) for the treatment of pilonidal disease. All adult patients treated with SiLaT in our... 相似文献
5.
埃克替尼联合抗血管药物一线治疗EGFR突变晚期肺腺癌的单中心研究 《首都医科大学学报》2022,43(2):289-293
目的 观察埃克替尼联合抗血管药物一线治疗表皮生长因子受体(epidermal growth factor receptor,EGFR)突变晚期肺腺癌的治疗效果和不良反应。方法 选取首都医科大学宣武医院胸科2018年6月1日至2019年12月31日期间,37例EGFR突变晚期肺腺癌的患者。采用埃克替尼(125 mg/次,3 次/d)联合贝伐单抗(7.5 mg/kg,1次/3周);或埃克替尼(125 mg/次,3 次/d)联合安罗替尼(10~12 mg 1次/d,第1~14天),均21 d为1个周期,至疾病进展或出现严重的不良反应后终止。中位随访时间14.5(9.2~30.8)个月。结果 本组患者中,62.2%(23/37)达到部分缓解,37.8% (14/37) 达到疾病稳定。客观有效率为62.2%(23/37),疾病控制率为100%(37/37)。中位疾病无进展时间为17.9个月(95% CI:10.292~25.508)个月。1年生存率为83.8%,18个月生存率为81.1%。多因素Cox回归分析结果显示,肝转移和脑转移对患者的PFS有明显影响(P<0.05)。最常见不良反应为皮疹(43.2%, 16/37)和腹泻(21.6%, 8/37)。结论 埃克替尼联合抗血管药物是一种有效且安全的一线治疗EGFR突变晚期肺腺癌的方案。 相似文献
6.
电磁导航支气管镜在肺外周病变诊断及治疗的临床应用 《首都医科大学学报》2022,43(4):570-575
随着低剂量螺旋电子计算机断层扫描(computed tomography,CT)应用于肺癌高危人群中的筛查越来越普及,肺外周病变(peripheral pulmonary lesions,PPLs)发现概率也随之增加。电磁导航支气管镜(electromagnetic navigation bronchoscopy,ENB)是一种能够进行肺部外周病变诊断、定位及治疗的工具,由于它的安全性和可靠性更高,ENB在未来有可能会改变肺部疾病的诊断和治疗方式,从而缓解病情甚至治愈肺癌,为肺癌的治疗开辟了新的路径。 相似文献
7.
Sleep and Breathing - Augmentation is a major complication of long-term pramipexole treatment of restless legs syndrome (RLS). However, there have been no studies on augmentation in Chinese... 相似文献
8.
目的用几种高度精细灵敏的方法检测氧糖剥夺再复氧(OGD/R)后神经元自噬流不同阶段的变化。方法原代皮质神经元细胞经过OGD/R后将实验分为OGD/R组及OGD/R+bafilomycin A1 (BafA1)组,用RFP-GFP串联荧光标记LC3基因转染检测自噬小体和溶酶体的融合情况,透射电子显微镜(TEM)观察自噬的超微结构,SQSTM1/p62结合LC3蛋白翻转实验检测p62与LC3蛋白的定量,p62免疫染色观测其分布与含量。结果荧光显微镜下OGD/R组自噬溶酶体与自噬小体比值明显增高;TEM可观测到不同阶段的自噬结构变化;可溶性p62的比值结合LC3Ⅱ/Ⅰ的比值共同反映了自噬流的活化;p62荧光染色后在BafA1组中分布居多。结论每种方法各有其优点,不同方法和指标能够精准地反映神经元OGD/R后自噬流在不同阶段的具体变化,掌握并应用好这些方法能有效从自噬角度探索中枢神经系统疾病。 相似文献
9.
10.